Dos and Don'ts in Health Technology Assessments

A session at Dos and Don'ts in Health Technology Assessments

Understand What is HTA - What it is Not
- Definitions
- Different types of HTA and the wide variety across countries
- 15 Key Principles

Thresholds Used by HTA Bodies in ICER-based Decision Making
- Recap of basic health economic principles (e.g. QALY, ICER ...)
- The variety of thresholds used across HTA bodies and how they influence decision making

Selecting from the Wide Range of Criteria
- Exploring the assessment criteria in HTA and their relative weight
- Using Multi-Criteria Decision Analysis (MCDA) to determine weights and influence decision making
- Trading off between criteria

Issues & Solutions for Optimising the Quality of the Evidence
- 'EMA' trials versus 'HTA' trials
- Reconciling the need for RRR vs. ARR data
- When to do ITT vs. when Per Protocol
- Compliance and Persistence are not synonyms!
- Extrapolating short term clinical data and surrogate endpoints
- Dealing with indirect effects

Effectively Working with HTA Processes Across the EU
- The optimal HTA process: does it exist?
- Learn from differences between countries
- The benefits and risks of international cooperation
- 'Adaptive' HTA and contracts based on outcomes guarantees

Summary of Dos and Don'ts and final discussion


Standard: EUR1.470

Speakers: Prof. Dr. Lieven Annemans

Category: Conferences | Science, Health and Medicine | Pharmaceuticals | Regulatory Affairs

Sign in to add slides, notes or videos to this session

Tell your friends!


Date Tue 9th June 2015

Short URL


Official event site


View the schedule


See something wrong?

Report an issue with this session